X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

United Kingdom In-Vitro Diagnostics Companies (2024 - 2029)

Several companies in the healthcare sector are making significant strides in their respective fields. These firms, ranging from diagnostics to pharmaceuticals, are leveraging innovative technologies to advance healthcare solutions. Some of these enterprises are renowned for their contributions in laboratory services, while others are recognized for their cutting-edge medical equipment. Furthermore, a few of these corporations are leading the way in the development of scientific instruments. These businesses continue to push the boundaries of what is possible in healthcare, contributing to a healthier and safer world.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research In-Vitro Diagnostics Market in the UK Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in United Kingdom In-Vitro Diagnostics Market

This report lists the top United Kingdom In-Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the United Kingdom In-Vitro Diagnostics industry.

  1. Thermo Fisher Scientific

  2. QIAGEN 

  3. Abbott Laboratories

  4. Siemens Healthineers

  5. Roche

*Disclaimer: Top companies sorted in no particular order

United Kingdom In-Vitro Diagnostics Market Major Players

United Kingdom In-Vitro Diagnostics Market Concentration

United Kingdom In-Vitro Diagnostics Market Concentration

United Kingdom In-Vitro Diagnostics Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

      3. 4.2.3 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value- USD Million)

    1. 5.1 By Technique

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Other Techniques

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Other Applications

    5. 5.5 By End-Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End-Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMerieux SA

      4. 6.1.4 Bio-Rad Laboratories, Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 QIAGEN N.V.

      8. 6.1.8 Siemens Healthineers AG

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 Thermo Fischer Scientific Inc.

      11. 6.1.11 Fujifilm Holdings Corporation

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to United Kingdom In-Vitro Diagnostics Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

United Kingdom In-Vitro Diagnostics Market Companies Summary

The in-vitro diagnostics market in the United Kingdom is highly competitive with several major players operating both globally and regionally. These corporations are responsible for the development and distribution of diagnostic kits, which have seen a surge in demand due to the COVID-19 pandemic and the increasing prevalence of chronic diseases. The growth of the market is further fueled by the rising demand for early and effective diagnostic tests, increased use of point-of-care diagnostics, and an increasing awareness and acceptance of personalized medicine and companion diagnostics. These businesses are also contributing to the market's growth through the introduction of point-of-care diagnostics and their increasing use. Furthermore, the launch of new products and technological developments within these firms are driving the growth of the studied market. Government initiatives in the UK are expected to boost the growth of the market, with programs aimed at increasing the number of samples tested for infectious diseases. However, stringent regulatory frameworks in the country are expected to impede the growth of the in-vitro diagnostics market.

Explore More

United Kingdom In-Vitro Diagnostics Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Abbott Laboratories

      2. 1.1.2 Becton, Dickinson and Company

      3. 1.1.3 BioMerieux SA

      4. 1.1.4 Bio-Rad Laboratories, Inc.

      5. 1.1.5 Danaher Corporation

      6. 1.1.6 F. Hoffmann-La Roche AG

      7. 1.1.7 QIAGEN N.V.

      8. 1.1.8 Siemens Healthineers AG

      9. 1.1.9 Sysmex Corporation

      10. 1.1.10 Thermo Fischer Scientific Inc.

      11. 1.1.11 Fujifilm Holdings Corporation

    2. *List Not Exhaustive

United Kingdom In-Vitro Diagnostics Companies FAQs

Thermo Fischer Scientific Inc., QIAGEN N.V., Abbott Laboratories, Siemens Healthcare GmbH and F. Hoffmann-La Roche AG are the major companies operating in the United Kingdom In-Vitro Diagnostics Market.

UK In-Vitro Diagnostics Market Report Snapshots

United Kingdom In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)